Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Clinical proteomics of the neglected human malarial parasite Plasmodium vivax.

Acharya P, Pallavi R, Chandran S, Dandavate V, Sayeed SK, Rochani A, Acharya J, Middha S, Kochar S, Kochar D, Ghosh SK, Tatu U.

PLoS One. 2011;6(10):e26623. doi: 10.1371/journal.pone.0026623. Epub 2011 Oct 20.

2.

Plasmodium vivax trophozoite-stage proteomes.

Anderson DC, Lapp SA, Akinyi S, Meyer EV, Barnwell JW, Korir-Morrison C, Galinski MR.

J Proteomics. 2015 Feb 6;115:157-76. doi: 10.1016/j.jprot.2014.12.010. Epub 2014 Dec 27.

3.

Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax.

Njuguna JT, Nassar M, Hoerauf A, Kaiser AE.

BMC Microbiol. 2006 Oct 16;6:91.

4.

In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.

Bouillon A, Giganti D, Benedet C, Gorgette O, PĂȘtres S, Crublet E, Girard-Blanc C, Witkowski B, MĂ©nard D, Nilges M, Mercereau-Puijalon O, Stoven V, Barale JC.

J Biol Chem. 2013 Jun 21;288(25):18561-73. doi: 10.1074/jbc.M113.456764. Epub 2013 May 7.

5.

Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2.

Patarroyo MA, Perez-Leal O, Lopez Y, Cortes J, Rojas-Caraballo J, Gomez A, Moncada C, Rosas J, Patarroyo ME.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):853-9. Epub 2005 Sep 29.

PMID:
16214111
6.

The march toward malaria vaccines.

Hoffman SL, Vekemans J, Richie TL, Duffy PE.

Vaccine. 2015 Nov 27;33 Suppl 4:D13-23. doi: 10.1016/j.vaccine.2015.07.091. Epub 2015 Aug 29. Review.

PMID:
26324116
7.

Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).

Udhayakumar V, Saekhou A, Fang S, Jue D, Wohlhueter RM, Lal AA.

Vaccine. 1998 May-Jun;16(9-10):982-8.

PMID:
9682348
8.

A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.

Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC.

PLoS Negl Trop Dis. 2015 Dec 23;9(12):e0004264. doi: 10.1371/journal.pntd.0004264. eCollection 2015 Dec.

9.

Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein.

Mongui A, Angel DI, Moreno-Perez DA, Villarreal-Gonzalez S, Almonacid H, Vanegas M, Patarroyo MA.

Malar J. 2010 Oct 13;9:283. doi: 10.1186/1475-2875-9-283.

10.

Identification of Plasmodium vivax-like human malaria parasite.

Qari SH, Shi YP, Goldman IF, Udhayakumar V, Alpers MP, Collins WE, Lal AA.

Lancet. 1993 Mar 27;341(8848):780-3.

PMID:
8095999
11.

Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites.

Michon P, Stevens JR, Kaneko O, Adams JH.

Mol Biol Evol. 2002 Jul;19(7):1128-42.

PMID:
12082132
12.

Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.

Rawat M, Vijay S, Gupta Y, Dixit R, Tiwari PK, Sharma A.

Infect Genet Evol. 2011 Jul;11(5):924-33. doi: 10.1016/j.meegid.2011.02.024. Epub 2011 Mar 5.

PMID:
21382523
13.

In silico identification of genetically attenuated vaccine candidate genes for Plasmodium liver stage.

Kumar H, Frischknecht F, Mair GR, Gomes J.

Infect Genet Evol. 2015 Dec;36:72-81. doi: 10.1016/j.meegid.2015.09.002. Epub 2015 Sep 6.

PMID:
26348884
14.

Proteomic approaches to studying drug targets and resistance in Plasmodium.

Cooper RA, Carucci DJ.

Curr Drug Targets Infect Disord. 2004 Mar;4(1):41-51. Review.

PMID:
15032633
15.

Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.

Bauza K, Malinauskas T, Pfander C, Anar B, Jones EY, Billker O, Hill AV, Reyes-Sandoval A.

Infect Immun. 2014 Mar;82(3):1277-86. doi: 10.1128/IAI.01187-13. Epub 2013 Dec 30.

16.

Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein.

Mongui A, Perez-Leal O, Soto SC, Cortes J, Patarroyo MA.

Biochem Biophys Res Commun. 2006 Dec 22;351(3):639-44. Epub 2006 Oct 24.

PMID:
17081497
17.

Plasmodium vivax: who cares?

Galinski MR, Barnwell JW.

Malar J. 2008 Dec 11;7 Suppl 1:S9. doi: 10.1186/1475-2875-7-S1-S9. Review.

18.

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.

Grimberg BT, Udomsangpetch R, Xainli J, McHenry A, Panichakul T, Sattabongkot J, Cui L, Bockarie M, Chitnis C, Adams J, Zimmerman PA, King CL.

PLoS Med. 2007 Dec;4(12):e337.

19.

Global occurrence of Plasmodium vivax-like human malaria parasite.

Qari SH, Shi YP, Povoa MM, Alpers MP, Deloron P, Murphy GS, Harjosuwarno S, Lal AA.

J Infect Dis. 1993 Dec;168(6):1485-9.

PMID:
8245533
20.

The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite.

Black CG, Barnwell JW, Huber CS, Galinski MR, Coppel RL.

Mol Biochem Parasitol. 2002 Apr 9;120(2):215-24.

PMID:
11897127

Supplemental Content

Support Center